Cargando…
Corrigendum to “Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study”
Autores principales: | Lin, Kun, Yang, Xiaoping, Wu, Yixi, Chen, Shuru, Zeng, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572609/ https://www.ncbi.nlm.nih.gov/pubmed/34754883 http://dx.doi.org/10.1155/2021/9830928 |
Ejemplares similares
-
Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study
por: Lin, Kun, et al.
Publicado: (2021) -
Corrigendum to “Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes”
por: Mottalib, Adham, et al.
Publicado: (2016) -
Corrigendum to “TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes”
por: Liu, Chen, et al.
Publicado: (2020) -
Corrigendum to “Five-Year Incidence and Progression of Diabetic Retinopathy in Patients with Type II Diabetes in a Tertiary Care Center in Lebanon”
por: Mehanna, Carl-Joe, et al.
Publicado: (2018) -
Corrigendum to “Antitumor Molecular Mechanism of Chlorogenic Acid on Inducting Genes GSK-3β and APC and Inhibiting Gene β-Catenin”
por: Xu, Ruoshi, et al.
Publicado: (2015)